Effect of steroids, acetyl-cysteine and calcium-activated chloride channel inhibitors on allergic mucin expression in sinus mucosa

Laryngoscope

Volumn 118, Issue 9, 2008, Pages 1528-1533

  Hauber, Hans Peter ^a   Steffen, Armin ^b   Goldmann, Torsten ^a   Vollmer, Ekkehard ^a   Hung, Hsiao Ling ^c   Wollenberg, Barbara ^b   Zabel, Peter ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Genaera Corporation   (United States)

Author keywords

Acetly cysteine; Dexamethasone; hCLCA1; Mucin; Th2 type cytokine; Upper airway mucosa

Indexed keywords

ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; CALCIUM ACTIVATED CHLORIDE CHANNEL INHIBITOR; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 9; MSI 2216; MUCIN; NIFLUMIC ACID; UNCLASSIFIED DRUG; CHLORIDE CHANNEL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MUCUS SECRETION; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT MUCOSA; TH2 CELL; UPPER RESPIRATORY TRACT; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; FOLLOW UP; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; SINUSITIS;

ACETYLCYSTEINE; ADULT; CELLS, CULTURED; CHLORIDE CHANNELS; CYTOKINES; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; MALE; MUCINS; NIFLUMIC ACID; PROSPECTIVE STUDIES; RESPIRATORY MUCOSA; SINUSITIS; TH2 CELLS;

EID: 51649104381     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31817b0732     Document Type: Article

References (23)

1. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-29.
2. Sanders SP, Zweier JL, Harrsion SJ, et al. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am J Respir Crit Care Med 1995;151: 1725-1733.
3. Dharajiya N., Choudhury BK, Bacsi A., et al. Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase-induced signal by intrapulmonary administration of antioxidants blocks allergic airway inflammation. J Allergy Clin Immunol 2007;119:646-653.
4. Nakanishi A., Morita S., Iwashita H., et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 2001;98:5175-5180.
5. Hauber HP, Goldmann T., Vollmer E., et al. LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res 2007; 13: 109-116.
6. Hauber HP, Daigneault P., Frenkeil S., et al. Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol 2005;115: 266-271.
7. Dandurand RJ, Wang CG, Laberge S., et al. In vitro allergic bronchoconstriction in the Brown Norway rat. Am J Respir Crit Care Med 1994;149:1499-1505.
8. Minshall E., Wang CG, Dandurand R., Eidelman D. Heterogeneity of responsiveness of individual airways in cultured lung explants. Can J Physiol Pharmacol 1997;75: 911-916.
9. Goldmann T., Vollmer E., Gerdes J. What's Cooking? Detection of important bio markers in HOPE-fixed, paraffinembedded tissues eliminates the need for antigen retrieval. Am J Pathol 2003;163:2638-2640.
10. Chen Y., Nickola TJ, DiFronzo NL, et al. Dexamethasonemediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2005; 34:338-347.
11. Lu W., Lillehoj E., Kim KC. Effects of dexamethasone on MUC5AC mucin production by primary airway goblet cells. Am J Physiol Lung Cell Mol Physiol 2005;288: L52-L60.
12. Redondo P., Jiminez E., Perez A., Garcia-Foncillas J. N-acetylcysteine downregulates vascular endothelial growth factor production by human keratinocytes in vitro. Arch Dermatol Res 2000;292:621-628.
13. Dabbagh K., Takeyama K., Lee HM, et al. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:6233-6237.
14. Longphre M., Li D., Gallup M., et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999;104:1375-1382.
15. Louahed J., Toda M., Jen J., et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000;22:649-656.
16. Zhu Z., Homer RJ, Wang Z., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
17. Kai H., Yoshitake K., Hisatsune A., et al. Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells. Am J Physiol 1996; 271:L484-L488.
18. Hauber HP, Goldmann T., Vollmer E., et al. Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa. Am J Respir Cell Mol Biol 2007; 37:606-616.
19. Sozzani P., Gambon C., Vita N., et al. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J Biol Chem 1995;270:5084-5088.
20. Harper RW, Xu C., Eiserich JP, et al. Differential regulation of dual NADPH oxidases/peroxidases, Duoxl and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005;579:4911-4917.
21. Lee KS, Kim SR, Park HS, et al. A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-lalpha. Exp Mol Med 2007;39: 756-768.
22. Naganishi, Nakano T., Inoue H., Fukuyama S., et al. Niflumic acid suppresses inter leukin-13 -induced asthma phenotypes. Am J Respir Crit Care Med 2006;173:1216-1221.
23. Civelli M., Vigano T., Acerbi D., et al. Modulation of arachidonic acid metabolism by orally administered momiflumate in man. Agents Actions 1991;33:233-239.